ReportsnReports.com: Antibody Drugs: Technologies and Global Markets

BCC Research’s new report “Antibody Drugs: Technologies and Global Markets” is now available at ReportsnReports.com
By: ReportsnReports
 
Feb. 6, 2012 - PRLog -- STUDY GOALS AND OBJECTIVES
The aim of this report is to provide a range of information—from detailed analysis through industry trends—to quantify and qualify the rapidly growing market for therapeutic monoclonal antibody (mAb) drugs.  Forecasts and trends are gleaned from industry sources, analyst reports, and company forecasts, as well as from assessment of available and emerging technologies.
The report develops forecasts for sales of the mAb market by individual antibody, by therapeutic antibody target (epidermal growth factor receptor [EGFR], cluster of differentiation [CD] 20, tumor necrosis factor [TNF] alpha, etc.), and by major disease applications from 2011 through 2016.  Additionally, we examine strategies employed by biopharmaceutical firms to develop and market products in this explosive market sector.
Our main objective is to present a comprehensive analysis of the current market for therapeutic mAb disease-modifying products and to forecast this market’s future direction through 2016.

Report Highlights
•   The global market for therapeutic monoclonal antibodies (mAbs) was estimated at $44.6 billion in 2011.  With the rollout of at least eight new therapeutic mAb products and expanded indications for existing products expected during the forecast period, the global mAb market is expected to rise at a compound annual growth rate (CAGR) of 5.3% to nearly $58 billion in 2016.
•   The U.S. is projected to be the largest single market for therapeutic mAbs from 2011 to 2016. This particular market was nearly $19.8 billion in 2010 and reached $20.1 billion by 2011. BCC projects this market will grow to $27.4 billion by 2016, a CAGR of 6.4%.
•   Sales of mAbs in the rest of the world will remain higher than in the U.S.—despite a higher CAGR in the U.S. versus the rest of the world. This market is expected to grow from $24.6 billion in 2011 to $30.3 billion in 2016 at a CAGR of 4.3%.

INTENDED AUDIENCE
This study will be of interest to those working in the biotechnology and pharmaceutical industries and related life science, drug discovery, and diagnostic test manufacturing companies, as well as all those interested or actively working in drug research.
Both individuals looking for a comprehensive listing of mAbs in human clinical-stage development and individuals looking at how the mAb drug marketplace is expected to change (in terms of sales and technology) in the coming years will find this report extremely useful.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/145559-antibody-dr...


About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com

# # #

ReportsnReports houses a comprehensive online library of more than 50,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites.
End
Source:ReportsnReports
Email:***@marketsandmarkets.com Email Verified
Tags:Drug Market, Drug Technology, Antibody Drug Market, Global Antibody Market, Pharma Industry, Pharmaceutical Research
Industry:antibody drugs
Location:United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Research Reports PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share